CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Oxidative Stress ELISA KitWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug655 Chloroquine Diphosphate Wiki 1.00
drug2161 Placebo oral tablet Wiki 0.18

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D013577 Syndrome NIH 0.10
D011014 Pneumonia NIH 0.06
D007239 Infection NIH 0.05
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials

1 Correlation Between Oxidative Stress Markers and COVID-19 Severity Index

During the new COVID-19 pandemic physicians all over the world have faced different challenges .Oxidative stress is a probable cause of multi organ failure in this setting which never has been evaluated in COVID-19 infection to the best of knowledge.Present study aimed to evaluate oxidative stress marker and redox system status in different COVID-19 patients regarding the severity of involvement.

NCT04375137 Oxidative Stress Diagnostic Test: Oxidative Stress ELISA Kit

Primary Outcomes

Description: MDA x 2 ULN in severe COVID

Measure: MDA concentration

Time: 2 weeks

Secondary Outcomes

Description: Difference between severe and controls

Measure: Biopterin concentration

Time: 2 weeks

Description: Difference between severe and controls

Measure: Neopterin rate of increase

Time: 2 weeks

No related HPO nodes (Using clinical trials)